# Yu‐Feng Wei

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yu-feng-wei/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,110 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 20 |
| i10-index | 37 |
| Last Known Institution | I-Shou University |
| OpenAlex ID | https://openalex.org/A5028509711 |
| ORCID iD | 0000-0002-6380-3527 |
| Works | 88 |

## Researcher papers

- [Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ramucirumab-plus-erlotinib-in-patients-with-untreated-egfr-mutated-advanced-non/)
- [Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report](https://scholariq.org/papers/osimertinib-plus-durvalumab-versus-osimertinib-monotherapy-in-egfr-t790m/)
- [Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study](https://scholariq.org/papers/datopotamab-deruxtecan-versus-docetaxel-for-previously-treated-advanced-or/)
- [Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study](https://scholariq.org/papers/low-dose-ct-screening-among-never-smokers-with-or-without-a-family-history-of/)
- [Factors responsible for poor sleep quality in patients with chronic obstructive pulmonary disease](https://scholariq.org/papers/factors-responsible-for-poor-sleep-quality-in-patients-with-chronic-obstructive/)
- [The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study](https://scholariq.org/papers/the-impact-of-2011-and-2017-global-initiative-for-chronic-obstructive-pulmonary/)
- [Impact of overweight and obesity on acute exacerbations of COPD – subgroup analysis of the Taiwan Obstructive Lung Disease cohort](https://scholariq.org/papers/impact-of-overweight-and-obesity-on-acute-exacerbations-of-copd-and-amp-ndash/)
- [Mortality and vertebral fracture risk associated with long-term oral steroid use in patients with chronic obstructive pulmonary disease: A systemic review and meta-analysis](https://scholariq.org/papers/mortality-and-vertebral-fracture-risk-associated-with-long-term-oral-steroid-use/)
- [Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing](https://scholariq.org/papers/resistance-profiles-of-anaplastic-lymphoma-kinase-tyrosine-kinase-inhibitors-in/)
- [Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma](https://scholariq.org/papers/different-pattern-of-pd-l1-ido-and-foxp3-tregs-expression-with-survival-in/)
- [Impact of Subsequent Treatment on Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Transformed to Small-Cell Lung Cancer](https://scholariq.org/papers/impact-of-subsequent-treatment-on-clinical-outcomes-in-patients-with-egfr-mutant/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [I-Shou University](https://scholariq.org/institutions/i-shou-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.